About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Social Capital Suvretta Holdings Corp III Cl A (NQ: DNAC )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 11, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 9.350 (1)
Ask (Size) 9.620 (1)
Prev. Close 9.280
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders
From Social Capital Suvretta Holdings Corp. III
Via Business Wire
DNAC Stock: 11 Things to Know Ahead of the ProKidney SPAC Merger
Palihapitiya's SPAC with ProKidney is expected to close during Q3 of this year. Here's what you need to know about the biotech company. 
Via InvestorPlace

Performance

More News

Read More
7 Worst SPACs for Smart Investors to Skip in 2022
Via InvestorPlace
ProKidney Turns To Palihapitiya-Backed SPAC To Go Public In $2.6B Deal
Via Benzinga
SOFI Stock: 11 Reasons Why Investors Are Banking On a SoFi Bank Charter
Via InvestorPlace
What Roblox Bulls Are Saying as RBLX Stock Trends Today
Via InvestorPlace
DNAC Stock Alert: Chamath Palihapitiya’s SPAC Preps for ProKidney Merger
Via InvestorPlace
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III
From Social Capital Suvretta Holdings Corp. III and ProKideny LP
Via Business Wire
2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again?
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Are Chamath Palihapitiya’s 4 New Biotech SPACs Worth a Look?
Via InvestorPlace
Social Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offering
From Social Capital Suvretta Holdings Corp. III
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.